These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 320926)

  • 1. Alterations in host responsiveness in patients with prostatic cancer following cryosurgery or transurethral resection.
    Ablin RJ; Bruns GR; Guinan PD; Sadoughi N; Sheik HA; Bush IM
    Am Surg; 1977 Mar; 43(3):144-50. PubMed ID: 320926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. II. Effect of oestrogen, cryosurgery and transurethral resection on thymic-dependent lymphocytic blastogenesis.
    Ablin RJ; Guinan PD; Bruns GR; Sheik HI; Sadoughi N; Bush IM
    Urol Int; 1976; 31(5):383-400. PubMed ID: 1087494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in immunoparameters following cryosurgery in prostate cancer].
    Fukagai T; Tazawa K; Higaki Y; Imamura K
    Hinyokika Kiyo; 1990 Mar; 36(3):307-17. PubMed ID: 2353604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible suppression of host resistance by estrogen therapy for prostatic cancer.
    Ablin RJ
    Can Med Assoc J; 1976 Dec; 115(11):1082-4. PubMed ID: 1000436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effects of oestrogen on immunologic responsiveness. I. Inhibition of DNA synthesis in peripheral blood lymphocytes from patients with Peyronie's disease, prostatic cancer and transsexuals and a commentary.
    Ablin RJ; Bruns GR; Guinan PD; Al Sheik H; Bush IM
    Eur Urol; 1979; 5(6):359-68. PubMed ID: 467472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic cancer after transurethral resection for benign prostatic hypertrophy].
    Fukuoka H; Takeda M; Nomura S; Shiba T; Sakanishi S
    Hinyokika Kiyo; 1992 Aug; 38(8):903-6. PubMed ID: 1384292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in tumor markers following cryosurgery of prostate carcinoma].
    Higaki Y; Imamura K
    Hinyokika Kiyo; 1989 Feb; 35(2):265-70. PubMed ID: 2472049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal therapy and alteration of lymphocyte proliferation.
    Ablin RJ; Bruns GR; Guinan PD; Al sheik H; Bush IM
    J Lab Clin Med; 1976 Feb; 87(2):227-31. PubMed ID: 1245789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subtotal transurethral prostatectomy in the treatment of patients with prostatic cancer].
    Mazo EB; Chepurov AK; Zoria OV
    Urologiia; 2005; (6):6-10. PubMed ID: 16419471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies of transurethral resection in patients with benign prostatic hypertrophy].
    Nakajima H; Mori K; Ohnishi S; Kato S; Tanda H
    Hinyokika Kiyo; 1988 Aug; 34(8):1411-4. PubMed ID: 2461645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery.
    Gould RS
    J Urol; 1999 Nov; 162(5):1653-7. PubMed ID: 10524891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does transurethral resection cause metastatic dissemination of hormone treated prostatic cancer?].
    Morote Robles J; Reig Ruiz C; Vila Barja J; Lorente Garin JA; López Pacios MA; de Torres Mateos JA; Soler Roselló A
    Actas Urol Esp; 1993 Mar; 17(3):187-9. PubMed ID: 8506773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of transurethral resection in cancer of the prostate].
    Rodríguez JV; Chechile G
    Arch Esp Urol; 1989; 42 Suppl 2():165-77. PubMed ID: 2639620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metastatic liver tumor arising from prostate cancer following transurethral resection of the prostate--a report of two cases].
    Yamamoto N; Zhang X; Soramoto S; Kuroda I; Ueda N; Yamashita M; Takenaka I
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):545-8. PubMed ID: 11329793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transurethral resection in prostatic cancer.
    Fujita K; Kimura T; Saito K; Sangen H; Furuhata T; Uyama K; Ogura K; Ueno F
    Clin Ther; 1988; 10 Spec No():12-5. PubMed ID: 2466566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immunity following double freezing of the prostate of patients with prostatic cancer.
    Ueda K; Ohtaguro K; Washida H; Jinno H; Fushimi N; Masegi T
    Prog Clin Biol Res; 1982; 107():815-26. PubMed ID: 7167530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic response to primary cryoablation of high-risk prostate cancer.
    Si T; Guo Z; Hao X
    Cryobiology; 2008 Aug; 57(1):66-71. PubMed ID: 18593573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum total creatine kinase and creatine kinase isoenzyme MB after cryosurgical ablation of the prostate.
    Long JP; Fallick ML; Rand W
    J Urol; 1997 May; 157(5):1723-6. PubMed ID: 9112513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.